I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC (PROPHET)
Are additional cycles of immunochemotherapy necessary for patients who have ctDNA clearance after initial cycles of treatment? Researchers will use ctDNA dynamics to guide the cycles of induction treatment to see if some patients can avoid excessive cycles of treatment.
- 0 views
- 19 May, 2025
Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC neoSCORE
This trial will also explore the biomarkers of neoadjuvant immunochemotherapy.
g-csf
neutrophil count
colony stimulating factor
angina pectoris
pneumonia
- 0 views
- 19 Feb, 2024